Lupus (SLE) trials in Singapore

2 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

  Where

  Singapore

  Age

  18 years to 100 years

  People

  348 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06711887 · EU 2024-515280-60-00
• No phaseTaking people
  Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

  Where

  Singapore, Tan Tock Seng

  Age

  18 years and over

  People

  5,000 worldwide

  Run by

  Monash University

  See details and how to joinNCT03138941